Robert E. Landry, EVP Finance CFO at REGENERON PHARMACEUTICALS, INC. (REGN), sold 1,801 shares at $695.50 ($1.3M) on 2022-04-01, disclosed to the SEC on 2022-04-01.
Open-market sale of $1.3M REGN by EVP Finance CFO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $700.99 | 1,184 | $830K | 65.9% |
| 2 | $695.50 | 301 | $209K | 16.6% |
| 3 | $695.50 | 301 | $209K | 16.6% |
| 4 | $701.98 | 15 | $11K | 0.8% |
| Total | $699.16 avg | 1,801 | $1.3M | 100% |
| Filing → |
| REGN | SELL | 2023-08-25 | $188K | — | Filing → |
| REGN | SELL | 2023-03-29 | $1.8M | — | Filing → |
| REGN | SELL | 2023-02-07 | $2.1M | — | Filing → |